Market Watch:

Mannatech, Incorporated, a leading developer and provider of dietary supplements and skin care solutions, announced today that the results of a recent randomized, double-blind, placebo-controlled, crossover human study indicate that Mannatech’s BounceBack(TM) capsules significantly reduce muscle soreness after overexertion.*

These results complement the already established benefits of BounceBack(TM) capsules in reducing soreness and stiffness from physical activity, and supporting optimal joint and cartilage health.*
This human clinical study, presented at the 2008 International Society of Sports Nutrition Conference and Expo, was published on Sept. 17 in the Journal of the International Society of Sports Nutrition. It was stringently designed and conducted “to evaluate the ability of BounceBack(TM) capsules to reduce the signs and symptoms of DOMS (delayed onset muscle soreness) and increase the rate of muscle recovery following eccentric exercise.”*

“The design of this study achieves the gold standard of a randomized, blinded and well-controlled, product-specific human study,” said Dr. Robert A. Sinnott, senior vice president and chief science officer at Mannatech. “The wellness industry has come a long way since the passage of the Dietary Supplement Health and Education Act in 1994. While the burden of scientific proof has become more stringent, these changes are for the better. Consumers are insisting on access to high quality products with proven performance. This is just one of the ways that Mannatech is working to open new frontiers in the area of nutritional science.”